Published in Kidney Int on April 01, 1987
The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions. Clin Exp Immunol (1991) 1.68
Complement and systemic lupus erythematosus. Arthritis Res (2002) 1.58
Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc Natl Acad Sci U S A (1991) 1.34
In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees. J Clin Invest (1989) 0.97
Multiple lupus-associated ITGAM variants alter Mac-1 functions on neutrophils. Arthritis Rheum (2013) 0.96
Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes. Clin Exp Immunol (1992) 0.92
Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment. Proc Natl Acad Sci U S A (1991) 0.84
First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104. Ann Rheum Dis (2004) 0.80
Complement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1. Infect Immun (1995) 0.80
A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding. Mol Immunol (2007) 0.78
Beta-thalassemia minor is associated with IgA nephropathy. Ann Lab Med (2013) 0.75
In vivo clearance by the mononuclear phagocyte system in humans: an overview of methods and their interpretation. Clin Exp Immunol (1992) 0.75
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50
Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest (1983) 3.57
Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker. Kidney Int (2007) 2.84
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int (2001) 2.17
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int (1999) 1.82
Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest (1966) 1.81
The living donor in kidney transplantation. Ann Intern Med (1987) 1.81
Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA (1976) 1.77
Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (1991) 1.66
Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest (1984) 1.46
Therapy of membranous nephropathy: what to do after the after (meta) analyses. J Am Soc Nephrol (1995) 1.39
Renoprotective therapy: how good can it get? Kidney Int (2000) 1.39
CR1 and CR1-like: the primate immune adherence receptors. Immunol Rev (2001) 1.27
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21
Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int (2007) 1.18
Renal artery dissection causing renal infarction in otherwise healthy men. Am J Kidney Dis (1997) 1.17
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest (1986) 1.11
5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10
Some hemodynamic determinants of immune complex trapping by the kidney. Kidney Int (1978) 1.05
Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate. Clin Immunol Immunopathol (1987) 1.04
Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res (2009) 1.03
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Am J Kidney Dis (1999) 1.02
Diagnostic significance of hypocomplementemia. Kidney Int (1991) 0.97
Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes. J Immunol (1987) 0.97
Measurement of the fractional uptake of macromolecules by the renal vascular bed compared to other vascular beds. J Lab Clin Med (1976) 0.97
Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J Immunol (1990) 0.95
Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol (1999) 0.93
Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus (2011) 0.92
Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare. Clin Exp Immunol (2006) 0.92
Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia. J Am Soc Nephrol (1997) 0.91
Factors influencing the binding of large immune complexes to the primate erythrocyte CR1 receptor. Clin Immunol Immunopathol (1984) 0.90
Measurement of SC5b-9 in urine in patients with the nephrotic syndrome. Kidney Int (1991) 0.90
Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus (2012) 0.85
Immune complexes bind preferentially to specific subpopulations of human erythrocytes. Clin Immunol Immunopathol (1990) 0.85
Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates. J Lab Clin Med (1990) 0.84
Of mice and men: the relevance of the mouse to the study of human SLE. Immunol Res (2001) 0.83
Reversal of chronic end-stage renal failure due to myeloma kidney. Ann Intern Med (1979) 0.83
Rapidly progressive glomerulonephritis superimposed on diabetic glomerulosclerosis. Recognition and treatment. JAMA (1982) 0.82
Renal subcapsular pressure--a new intrarenal pressure measurement. Am J Physiol (1971) 0.82
Effect of renal decapsulation on renal function. Am J Physiol (1975) 0.80
Renal artery pressure gradients in patients with angiographic evidence of atherosclerotic renal artery stenosis. Am J Kidney Dis (1994) 0.80
Stability of renal transplant function with alternate-day corticosteroid therapy. JAMA (1980) 0.79
A comparison of taste acuity for salt in renal patients vs. normal subjects. J Am Diet Assoc (1987) 0.78
Renal expansion in saline loading. Am J Physiol (1974) 0.78
Adverse effect of exercise on immune complex-mediated glomerulonephritis. Nephron (1985) 0.78
Simple method for monitoring 24-hour urinary urea nitrogen excretion. J Lab Clin Med (1986) 0.78
Renal autotransplantation in the loin pain-hematuria syndrome: a cautionary note. Am J Kidney Dis (1992) 0.78
Primary hypothyroidism in chronic renal failure. Clin Nephrol (1986) 0.77
Platelet inhibitors in human renal homotransplantation: randomized comparison of aspirin versus dipyridamole. Transplant Proc (1980) 0.77
Whole kidney volume/pressure relationships. Kidney Int (1975) 0.76
Human erythrocytes inhibit complement-mediated solubilization of immune complexes. J Immunol (1989) 0.76
Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patients. Kidney Int (1996) 0.76
Plasmapheresis in the treatment of renal allograft rejection. Proc Clin Dial Transplant Forum (1979) 0.76
Management of urinary tract infections. N Engl J Med (1994) 0.75
Method for detecting a progressive renal disorder superimposed on a preexisting progressive renal disorder. Am J Kidney Dis (1981) 0.75
Glomerular basement membrane splitting and microaneurysm formation associated with nitrosourea therapy. Am J Nephrol (1985) 0.75
Metacarpophalangeal joint replacement. Case report of 20-year follow-up. Phys Ther (1979) 0.75
Angiotensin as a possible intrarenal hormone in isolated dog kidneys. Circ Res (1973) 0.75
Effect of glucocorticoids on WBC counts in splenectomized renal transplant recipients. Arch Intern Med (1978) 0.75
[Silicosis with short exposure time]. Bol Oficina Sanit Panam (1971) 0.75
On the natural tendency for renal disease to progress: can interventions slow this progression? Trans Assoc Life Insur Med Dir Am (1989) 0.75
Potassium depletion and hypercapnia. N Engl J Med (1969) 0.75
Effects of immune complex formation and complement activation on circulating platelets in the primate. Clin Immunol (1999) 0.75
Light-chain proteinuria: spurious false-negative reaction to sulfosalicylic acid. Ann Intern Med (1985) 0.75
[Hematic and cardiopulmonary characteristics of the Andean miner]. Bol Oficina Sanit Panam (1972) 0.75
Infantile polycystic kidney disease in the adult. Arch Intern Med (1977) 0.75
Building peer contact within a group practice. Phys Ther (1979) 0.75
Skin depigmentation related to transdermal clonidine therapy. Arch Intern Med (1995) 0.75
[Complement in kidney diseases]. Rev Clin Esp (1996) 0.75
Body at work. Occup Health Saf (1992) 0.75
Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysis. Clin Pharm (1985) 0.75
Mining work in high altitude. Arch Environ Health (1969) 0.75
Habitual excessive dietary salt intake and blood pressure levels in renal transplant recipients. Am J Med (1982) 0.75
[Peripheral arterial disease in a population of type 2 diabetic patients: its correlation with diabetic microangiopathy and laboratory parameters]. Minerva Cardioangiol (2003) 0.75
Renal volume-pressure and functional relationships in acute allograft rejection. Transplantation (1980) 0.75
Apheresis is of value in SLE. Trans Am Soc Artif Intern Organs (1984) 0.75
Analytical focus reduces anxiety over CTD claims. Occup Health Saf (1993) 0.75
Effect of expansion of renal parenchymal volume on renal function. Nephron (1978) 0.75
Operative risks: the clinical evaluation and management of disorders of water and electrolyte balance. Clin Obstet Gynecol (1973) 0.75
Effect of moderate daily exercise on acute glomerulonephritis. Nephron (1981) 0.75
Platelet involvement in experimental immune complex-mediated glomerulonephritis in the nonhuman primate. Kidney Int (1993) 0.75